Navigation Links
Eastern Clinical Trials Russia CRO Passes EMA Inspection

Moscow, Russia (PRWEB) February 12, 2013

Moscow, Russia January 31, 2013 -- Eastern Clinical Trials (ECT), a leading contract research organization (CRO) with operations in Russia and Central and Eastern Europe, announced today that it successfully passed with no major findings an inspection conducted by the European Medicines Agency (EMA).

The Inspection was conducted on 22-24 January 2013 at the site of Professor Sergey V. Orlov MD, PhD, of Saint Petersburg State Medical University, who is a principal investigator in a large registration oncology trial.

“We are very pleased to have passed the EMA Inspection” commented Dr. Svetlana Vodolazhskaya, Managing Director of Eastern Clinical Trials. “The Agency’s inspection results confirm that ECT's clinical research operations meet and often exceed international standards. We realize the importance of efficient operations that meet our client’s high requirements in drug development process and take great pride in both the quality of our work and in ECT's exceptional team of professionals.”

About Eastern Clinical Trials (ECT)(
Established in 2004, Eastern Clinical Trials (ECT) has grown from a local Moscow-based CRO to a trusted regional partner in clinical research with operations in Russia, Ukraine, Belarus, Georgia, Hungary and Slovakia. ECT provides a full spectrum of clinical trial services including project management, monitoring, study feasibility, regulatory submission and support, translation, safety reporting and warehousing.

Svetlana Vodolazhskaya, MD
Managing Director
Russia 119034 Moscow
Tel: + 7(925)5023189

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Northeastern University Nanomanufacturing Center Director Ahmed Busnaina to Present Webinar on “The Democratization of Manufacturing”
2. Reminder: Spherix to Hold Business Update Conference Call April 11 at 1:00 p.m. Eastern Time
3. ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188
4. Galectin-3 Assessed as a Biomarker of Heart Failure: Key Clinical Trial Findings Published by Dove Medical Press
5. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
6. Cutting the Cost of Clinical Research: The Solution Comes from Russia, New Xtalks Webinar
7. OpenClinica to Exhibit at SCOPE (Summit for Clinical Ops Executives)
8. Infinata's BioPharm Clinical™ to Present Session on Improving Investigator Selection at CHI’s Summit for Clinical Operations (SCOPE) on February 6 in Miami, FL
9. Migraines Found Linked to Nighttime Teeth Grinding & Clenching in TMJ Treatment Clinical Trial - Holistic Technologies
10. MC Leeuwarden Selects ClinicalKey
11. ComplianceOnline Announces Seminar on Clinical Trial Project Supplier Quality Improvement
Post Your Comments:
(Date:10/9/2015)... ... October 09, 2015 , ... Leading microbial genomics startup ... to better understand the relationship between weight management and the microbiome. The study uses ... from participants using an iPhone app. , The uBiome app is available as a ...
(Date:10/8/2015)... DIEGO , Oct. 8, 2015  Sorrento ... company developing new treatments for cancer and associated ... Executive Officer, will be presenting at the Aegis ... Las Vegas :Event:Aegis Capital Corporation 2015 Growth ... 2 room, The Encore @ The Wynn in ...
(Date:10/8/2015)... and WAYNE, Pa. , ... and technology consulting firm, has announced the call for ... Pennsylvania , majoring in a life sciences ... a two-year period. In addition, the selected Clarkston Scholar ... mentoring with Clarkston Consulting and participation in Pennsylvania Bio ...
(Date:10/8/2015)... PORTLAND, Oregon , October 8, 2015 /PRNewswire/ ... . --> Global Biologics and Biosimilars ... added a report "Global Biologics and Biosimilars Industry ... Growth, Analysis and Forecast" is a professional and ... Biosimilars industry . ) , ...
Breaking Biology Technology:
... Corporation,(NYSE: STE ) today announced financial results for ... 2009 second quarter revenues,increased 10% to $323.1 million compared ... driven by strong growth in all three business,segments. Fiscal ... $0.48,per diluted share, compared with net income of $16.0 ...
... Samadi, M.D., a world renowned urologic oncologist, discusses his breakthrough robotic ... nerves, tissues, and organs responsible for sexual function and continence. To ... the results are quite pleasing for his patients. , ... ...
... BioMed Realty Trust, Inc.,(NYSE: BMR ), a real ... science industry, today announced financial results for,the third quarter ended ... revenues increased 24.6% to $80.8 million from ... Completed delivery of the 84,000 square foot build-to-suit laboratory ...
Cached Biology Technology:
(Date:10/5/2015)... , October 5, 2015 ... company update for NXT-ID, Inc. (NASDAQ: NXTD ), ... commerce market. --> ) ... Inc. (NASDAQ: NXTD ), a biometric authentication company ... SoundView Technology Group ( ) ...
(Date:9/30/2015)... YORK , Sept. 30, 2015  The global glucose ... billion for 2015. So says a new report on the ... diabetes management segment dominate the market, followed by continuous glucose ... publisher. Kalorama reports on the market for these products in its ... ...
(Date:9/28/2015)... 28, 2015 The global ... USD 12.03 billion by 2020, growing at a CAGR ... as Backside Illumination (BSI) technique to improve picture quality ... period.      (Logo: , ... to reduce loss and, thus, reduce the noise interference ...
Breaking Biology News(10 mins):
... , Today, Andrew Viterbi, Donald Bitzer and John Daugman ... Inventors Hall of Fame at the United States Patent ... and their accomplishments are in part a testimony to ... Viterbi, an electrical engineer and cofounder of wireless ...
... appearing in the Journal of Nutritional Biochemistry demonstrates that ... chronic high blood pressure (hypertension) by increasing the activity ... heart tissue. Grapes are a known natural source ... be responsible for the beneficial effects observed with grape ...
... that aimed to understand how the cancer drug everolimus ... trastuzumab has left researchers contemplating a puzzle. , The ... rates for some patients with early breast cancer when ... results suggest this benefit is achieved independently of the ...
Cached Biology News:
... Microarrays designed for genome-wide microRNA ... flexible and powerful Paraflo microfluidic on-chip ... as part of our comprehensive microRNA ... Content The Viruses microRNA Microarray ...
... LTQ XL extends the legendary MSn performance ... generate structural information through Thermo Scientifics innovations ... LTQ XL is the only mass spectrometer ... and CID. Pulsed Q Collision Induced ...
... The reliable and compact GC-8A is Shimadzu's ... Economical and simple to use, the GC-8A ... flow control, on column injection port(s), and ... program models are available. The GC-8A is ...
... The 6820 GC system combines world-class ... Chemical QA/QC software, Agilents world-renowned support and ... consumables and supplies--a combination that lets you ... decisions based on dependable data. The Agilent ...
Biology Products: